ABCL

AbCellera Biologics Inc.

4.96 USD
+0.11 (+2.27%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

AbCellera Biologics Inc. stock is down -5.7% since 30 days ago. The next earnings date is May 2, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 3 February’s closed higher than January. In the last 3 Unusual Options Trades, there were 3 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
26 Dec 16:28 17 Jan, 2025 3.00 CALL 100 353
26 Dec 18:17 17 Jan, 2025 5.00 CALL 180 1979
10 Jan 20:50 17 Jan, 2025 8.00 CALL 349 1197

About AbCellera Biologics Inc.

AbCellera Biologics Inc. has 156 discovery programs that are either completed, in progress, or under contract with 36 partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.